Holdings

Invesco Health Care Fund

As of Jul 31, 2026, Invesco Health Care Fund reported 78 positions worth US$1.18B. Largest: Eli Lilly and Company, Johnson & Johnson and UnitedHealth Group Incorporated. What it bought and sold, with each filing.

Holdings

Part of
Invesco
Positions
78
Value as reported
US$1.18B
Holdings as of
Jul 31, 2026
Last filed
Sep 28, 2026
CompanySharesValue as reported% of portfolioChangeAs of
Eli Lilly and Company
NYSE:LLY
111KUS$128M10.6%−5,504Jul 31, 2026
Johnson & Johnson
NYSE:JNJ
318KUS$81.6M6.8%+30,790Jul 31, 2026
UnitedHealth Group Incorporated
NYSE:UNH
180KUS$74.4M6.2%+63,953Jul 31, 2026
Merck & Company, Inc.
NYSE:MRK
426KUS$55.4M4.6%+191KJul 31, 2026
AbbVie Inc.
NYSE:ABBV
194KUS$48.6M4.0%No changeJul 31, 2026
Gilead Sciences, Inc.
NASDAQ:GILD
337KUS$43.9M3.6%No changeJul 31, 2026
argenx SE
EURONEXT:ARGX
45,770US$39.1M3.2%−7,206Jul 31, 2026
CVS Health Corporation
NYSE:CVS
291KUS$30.4M2.5%+66,820Jul 31, 2026
Welltower Inc.
NYSE:WELL
120KUS$28.2M2.3%No changeJul 31, 2026
BrightSpring Health Services, Inc.
NASDAQ:BTSG
445KUS$26.5M2.2%−37,560Jul 31, 2026
Royalty Pharma plc
NASDAQ:RPRX
441KUS$25.8M2.1%No changeJul 31, 2026
Cardinal Health, Inc.
NYSE:CAH
110KUS$25.3M2.1%+7,524Jul 31, 2026
Guardant Health, Inc.
NASDAQ:GH
152KUS$24.7M2.0%No changeJul 31, 2026
Vertex Pharmaceuticals Incorporated
NASDAQ:VRTX
50,958US$24.3M2.0%No changeJul 31, 2026
Axsome Therapeutics, Inc.
NASDAQ:AXSM
87,700US$19.1M1.6%No changeJul 31, 2026
Edwards Lifesciences Corporation
NYSE:EW
219KUS$18.9M1.6%+26,356Jul 31, 2026
Thermo Fisher Scientific Inc
NYSE:TMO
32,631US$18.7M1.6%+15,027Jul 31, 2026
BridgeBio Pharma, Inc.
NASDAQ:BBIO
216KUS$17.3M1.4%No changeJul 31, 2026
Waters Corporation
NYSE:WAT
45,153US$17M1.4%NewJul 31, 2026
IQVIA Holdings, Inc.
NYSE:IQV
67,768US$15.9M1.3%NewJul 31, 2026
Ucb S.A.
EURONEXT:UCB
58,259US$15M1.2%No changeJul 31, 2026
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND
49,408US$14.2M1.2%+3,760Jul 31, 2026
Protagonist Therapeutics, Inc.
NASDAQ:PTGX
104KUS$14.2M1.2%No changeJul 31, 2026
Natera, Inc.
NASDAQ:NTRA
52,670US$14.1M1.2%−11,082Jul 31, 2026
Sandoz Group Ltd
SIX:SDZ
169KUS$13.8M1.1%No changeJul 31, 2026
Ascendis Pharma A/S
NASDAQ:ASND
54,101US$13.2M1.1%−154Jul 31, 2026
Revolution Medicines, Inc.
NASDAQ:RVMD
69,866US$13.1M1.1%+11,302Jul 31, 2026
Amgen Inc.
NASDAQ:AMGN
33,407US$12.9M1.1%NewJul 31, 2026
Halozyme Therapeutics, Inc.
NASDAQ:HALO
155KUS$12.8M1.1%No changeJul 31, 2026
United Therapeutics Corporation
NASDAQ:UTHR
23,038US$11.9M0.99%No changeJul 31, 2026
Quest Diagnostics Incorporated
NYSE:DGX
50,956US$11.9M0.98%+15,035Jul 31, 2026
Mettler-Toledo International, Inc.
NYSE:MTD
7,844US$11.1M0.92%−2,635Jul 31, 2026
Charles River Laboratories International, Inc.
NYSE:CRL
47,533US$11.1M0.92%+34,481Jul 31, 2026
Intuitive Surgical, Inc.
NASDAQ:ISRG
30,687US$10.8M0.90%No changeJul 31, 2026
Galderma Group AG
SIX:GALD
49,726US$10.8M0.90%No changeJul 31, 2026
Medline Inc.
NASDAQ:MDLN
265KUS$10.4M0.86%No changeJul 31, 2026
Madrigal Pharmaceuticals, Inc.
NASDAQ:MDGL
21,162US$9.89M0.82%No changeJul 31, 2026
AstraZeneca PLC
LSE:AZN
56,196US$9.53M0.79%−196KJul 31, 2026
West Pharmaceutical Services, Inc.
NYSE:WST
27,934US$9.52M0.79%NewJul 31, 2026
Labcorp Holdings Inc.
NYSE:LH
27,780US$8.59M0.71%No changeJul 31, 2026
Lonza Group AG
SIX:LONN
12,228US$8.52M0.71%−2,660Jul 31, 2026
Cytokinetics, Incorporated
NASDAQ:CYTK
108KUS$8.32M0.69%+59,725Jul 31, 2026
Tenet Healthcare Corporation
NYSE:THC
31,528US$8.03M0.67%−15,041Jul 31, 2026
STERIS plc (Ireland)
NYSE:STE
33,121US$7.56M0.63%No changeJul 31, 2026
Krystal Biotech, Inc.
NASDAQ:KRYS
20,337US$6.94M0.57%NewJul 31, 2026
Arrowhead Pharmaceuticals, Inc.
NASDAQ:ARWR
81,814US$6.93M0.57%+22,271Jul 31, 2026
Globus Medical, Inc.
NYSE:GMED
87,598US$6.9M0.57%No changeJul 31, 2026
Twist Bioscience Corporation
NASDAQ:TWST
74,708US$6.84M0.57%No changeJul 31, 2026
Medpace Holdings, Inc.
NASDAQ:MEDP
11,793US$6.81M0.56%+3,132Jul 31, 2026
Encompass Health Corporation
NYSE:EHC
53,477US$5.94M0.49%−33,874Jul 31, 2026
Alignment Healthcare, Inc.
NASDAQ:ALHC
384KUS$5.71M0.47%No changeJul 31, 2026
Rhythm Pharmaceuticals, Inc.
NASDAQ:RYTM
57,008US$5.66M0.47%+26,325Jul 31, 2026
Humana Inc.
NYSE:HUM
15,045US$5.47M0.45%NewJul 31, 2026
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
16,575US$5.1M0.42%NewJul 31, 2026
Teva Pharmaceutical Industries Limited
TASE:TEVA
145KUS$5.06M0.42%NewJul 31, 2026
Cogent Biosciences, Inc.
NASDAQ:COGT
124KUS$4.83M0.40%+49,924Jul 31, 2026
Mirum Pharmaceuticals, Inc.
NASDAQ:MIRM
45,043US$4.77M0.40%+15,080Jul 31, 2026
BioLife Solutions, Inc.
NASDAQ:BLFS
152KUS$4.74M0.39%No changeJul 31, 2026
BillionToOne, Inc.
NASDAQ:BLLN
33,606US$4.66M0.39%+18,838Jul 31, 2026
Rapport Therapeutics, Inc.
NASDAQ:RAPP
110KUS$4.51M0.37%No changeJul 31, 2026
LeMaitre Vascular, Inc.
NASDAQ:LMAT
44,039US$4.46M0.37%No changeJul 31, 2026
Centene Corporation
NYSE:CNC
65,007US$4.04M0.34%NewJul 31, 2026
RadNet, Inc.
NASDAQ:RDNT
62,732US$4M0.33%No changeJul 31, 2026
IDEXX Laboratories, Inc.
NASDAQ:IDXX
6,940US$3.88M0.32%−16,571Jul 31, 2026
Glaukos Corporation
NYSE:GKOS
22,572US$3.76M0.31%NewJul 31, 2026
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
33,618US$3.59M0.30%No changeJul 31, 2026
Xenon Pharmaceuticals Inc.
NASDAQ:XENE
52,646US$3.3M0.27%No changeJul 31, 2026
Bruker Corporation
NASDAQ:BRKR
50,580US$3.18M0.26%NewJul 31, 2026
Heartflow, Inc.
NASDAQ:HTFL
121KUS$3.06M0.25%No changeJul 31, 2026
Tarsus Pharmaceuticals, Inc.
NASDAQ:TARS
50,546US$2.98M0.25%No changeJul 31, 2026
Palvella Therapeutics, Inc.
NASDAQ:PVLA
20,783US$2.89M0.24%No changeJul 31, 2026
Incyte Corporation
NASDAQ:INCY
22,546US$2.69M0.22%NewJul 31, 2026
uniQure N.V.
NASDAQ:QURE
52,763US$2.3M0.19%NewJul 31, 2026
Edgewise Therapeutics, Inc.
NASDAQ:EWTX
44,189US$1.7M0.14%NewJul 31, 2026
Kiniksa Pharmaceuticals International, plc
NASDAQ:KNSA
22,546US$1.68M0.14%NewJul 31, 2026
Phathom Pharmaceuticals, Inc.
NASDAQ:PHAT
185KUS$1.62M0.13%No changeJul 31, 2026
GMR Solutions Inc.
NYSE:GMRS
121KUS$1.56M0.13%NewJul 31, 2026
Mineralys Therapeutics, Inc.
NASDAQ:MLYS
56,401US$1.44M0.12%NewJul 31, 2026